CURE vs VYM
Direxion Daily Healthcare Bull 3X ETF vs Vanguard High Dividend Yield ETF
Quick Verdict
VYM has a lower expense ratio. CURE delivered stronger 1-year returns. VYM offers more diversification with 558 holdings.
Side-by-Side Comparison
| Metric | CURE | VYM | Winner |
|---|---|---|---|
| Expense Ratio | 0.94% | 0.04% | |
| AUM | $181M | $79.0B | |
| Dividend Yield | 1.12% | 2.86% | |
| Holdings | 67 | 568 | |
| YTD Return | +11.58% | +15.80% | |
| 1Y Return | +87.78% | +26.12% | |
| 3Y Return (annualized) | +7.97% | +18.25% | |
| 5Y Return (annualized) | +1.36% | +12.51% | |
| Volatility (annualized) | 41.9% | 14.6% | |
| Max Drawdown | -69.2% | -58.8% | |
| Fund Family | Direxion Shares ETF Trust | Vanguard (US) | |
| Category | Alternative | Equity | |
| Inception | Jun 15, 2011 | Nov 10, 2006 |
CURE vs VYM Performance
Direxion Daily Healthcare Bull 3X ETF (CURE) is a ETF from Direxion Shares ETF Trust and Vanguard High Dividend Yield ETF (VYM) is a ETF from Vanguard (US). Over the past year CURE returned +87.78% while VYM returned +26.12%. Year to date, CURE is up 11.58% versus a gain of 15.80% for VYM.
Over three years, CURE compounded at +7.97% per year against +18.25% for VYM; over five years the annualized figures are +1.36% and +12.51% respectively. Across the full 15-year window we track, CURE has the edge at +24.18% annualized vs +7.07%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
CURE has been the more volatile fund, with annualized monthly volatility of 41.9% compared with 14.6% for VYM. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -69.2% for CURE and -58.8% for VYM. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.77. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
CURE charges 0.94% per year while VYM charges 0.04%. On a $10,000 position that is $94 vs $4 annually, a gap of $90 per year that compounds over a long holding period. On income, CURE currently yields 1.12% against 2.86% for VYM.
Holdings Overlap
CURE and VYM share 18 holdings out of 602 unique holdings combined, representing a 13.1% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, CURE or VYM?
CURE has an expense ratio of 0.94% while VYM charges 0.04%. VYM is the cheaper option. On a $10,000 investment, that is $90 per year of difference.
Which performed better, CURE or VYM?
Over the past year CURE returned +87.78% vs +26.12% for VYM, so CURE leads on 1-year performance. Over the longest common window we track (15 years), CURE annualized +24.18% vs +7.07% for VYM. Past performance does not guarantee future results.
Which is riskier, CURE or VYM?
CURE has been the more volatile fund at 41.9% annualized versus 14.6% for VYM. Worst drawdown: CURE -69.2% vs VYM -58.8%.
Should I hold both CURE and VYM?
CURE and VYM have a monthly-return correlation of 0.77, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between CURE and VYM?
CURE and VYM share 18 common holdings with a 13.1% weight overlap. Combined, they hold 602 unique securities.
Which pays a higher dividend, CURE or VYM?
CURE yields 1.12% while VYM yields 2.86%, so VYM currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.